Ann: Supplementary NYR-BI03 Study Confirm Strong Cardioprotection, page-42

  1. 1,217 Posts.
    lightbulb Created with Sketch. 156
    Zecs your right mate I agree

    Mate I really don’t care what you have to say but you’re a troll. Even if they raise 2 million right now before phase 1 to complete the study and have the runway to non dilutive funding and through phase 2 I don’t even care mate, I’ll be part of that raise. The company is made with these announcements fundamentally. At each stage this will continue to rerate and the upside is multiples. Keep trolling

    But I do have a feeling that people are not investing for this confirmation and I have a gut feeling it’s coming and once it’s done it’s rerating. My gut is never wrong
    Last edited by Bendunstan: 23/10/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
24.5¢
Change
0.000(0.00%)
Mkt cap ! $51.67M
Open High Low Value Volume
24.5¢ 25.0¢ 23.5¢ $211.2K 865.1K

Buyers (Bids)

No. Vol. Price($)
2 17007 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 85141 1
View Market Depth
Last trade - 15.50pm 23/06/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.